0001929783 2025-10-01 2026-03-31 0001929783 2026-03-31 0001929783 2025-09-30 0001929783 us-gaap:RelatedPartyMember 2026-03-31 0001929783 us-gaap:RelatedPartyMember 2025-09-30 0001929783 us-gaap:CommonClassAMember 2026-03-31 0001929783 us-gaap:CommonClassAMember 2025-09-30 0001929783 us-gaap:CommonClassBMember 2026-03-31 0001929783 us-gaap:CommonClassBMember 2025-09-30 0001929783 wok:ThirdPartiesMember 2025-10-01 2026-03-31 0001929783 wok:ThirdPartiesMember 2024-10-01 2025-03-31 0001929783 us-gaap:RelatedPartyMember 2025-10-01 2026-03-31 0001929783 us-gaap:RelatedPartyMember 2024-10-01 2025-03-31 0001929783 2024-10-01 2025-03-31 0001929783 us-gaap:CommonStockMember 2024-09-30 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-09-30 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-09-30 0001929783 us-gaap:ReceivablesFromStockholderMember 2024-09-30 0001929783 us-gaap:AdditionalPaidInCapitalMember 2024-09-30 0001929783 wok:StatutoryReservesMember 2024-09-30 0001929783 us-gaap:RetainedEarningsMember 2024-09-30 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-09-30 0001929783 us-gaap:ParentMember 2024-09-30 0001929783 us-gaap:NoncontrollingInterestMember 2024-09-30 0001929783 2024-09-30 0001929783 us-gaap:CommonStockMember 2024-10-01 2025-03-31 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2024-10-01 2025-03-31 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2024-10-01 2025-03-31 0001929783 us-gaap:ReceivablesFromStockholderMember 2024-10-01 2025-03-31 0001929783 us-gaap:AdditionalPaidInCapitalMember 2024-10-01 2025-03-31 0001929783 wok:StatutoryReservesMember 2024-10-01 2025-03-31 0001929783 us-gaap:RetainedEarningsMember 2024-10-01 2025-03-31 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2024-10-01 2025-03-31 0001929783 us-gaap:ParentMember 2024-10-01 2025-03-31 0001929783 us-gaap:NoncontrollingInterestMember 2024-10-01 2025-03-31 0001929783 us-gaap:CommonStockMember 2025-03-31 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-03-31 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-03-31 0001929783 us-gaap:ReceivablesFromStockholderMember 2025-03-31 0001929783 us-gaap:AdditionalPaidInCapitalMember 2025-03-31 0001929783 wok:StatutoryReservesMember 2025-03-31 0001929783 us-gaap:RetainedEarningsMember 2025-03-31 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-03-31 0001929783 us-gaap:ParentMember 2025-03-31 0001929783 us-gaap:NoncontrollingInterestMember 2025-03-31 0001929783 2025-03-31 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-09-30 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-09-30 0001929783 us-gaap:ReceivablesFromStockholderMember 2025-09-30 0001929783 us-gaap:AdditionalPaidInCapitalMember 2025-09-30 0001929783 us-gaap:RetainedEarningsAppropriatedMember 2025-09-30 0001929783 us-gaap:RetainedEarningsMember 2025-09-30 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-09-30 0001929783 us-gaap:ParentMember 2025-09-30 0001929783 us-gaap:NoncontrollingInterestMember 2025-09-30 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-10-01 2026-03-31 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-10-01 2026-03-31 0001929783 us-gaap:ReceivablesFromStockholderMember 2025-10-01 2026-03-31 0001929783 us-gaap:AdditionalPaidInCapitalMember 2025-10-01 2026-03-31 0001929783 us-gaap:RetainedEarningsAppropriatedMember 2025-10-01 2026-03-31 0001929783 us-gaap:RetainedEarningsMember 2025-10-01 2026-03-31 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2025-10-01 2026-03-31 0001929783 us-gaap:ParentMember 2025-10-01 2026-03-31 0001929783 us-gaap:NoncontrollingInterestMember 2025-10-01 2026-03-31 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-03-31 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-03-31 0001929783 us-gaap:ReceivablesFromStockholderMember 2026-03-31 0001929783 us-gaap:AdditionalPaidInCapitalMember 2026-03-31 0001929783 us-gaap:RetainedEarningsAppropriatedMember 2026-03-31 0001929783 us-gaap:RetainedEarningsMember 2026-03-31 0001929783 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2026-03-31 0001929783 us-gaap:ParentMember 2026-03-31 0001929783 us-gaap:NoncontrollingInterestMember 2026-03-31 0001929783 us-gaap:IPOMember 2024-08-26 2024-08-26 0001929783 us-gaap:IPOMember 2024-08-26 0001929783 us-gaap:OverAllotmentOptionMember 2024-08-26 2024-08-26 0001929783 us-gaap:OverAllotmentOptionMember 2024-08-26 0001929783 wok:HangzhouShanyouOneMember 2022-01-17 2022-01-17 0001929783 wok:BaimingYuMember 2022-01-17 2022-01-17 0001929783 wok:LiweiZhangMember 2022-01-17 2022-01-17 0001929783 wok:LWYGROUPLTDMember us-gaap:CommonStockMember 2022-03-01 0001929783 2022-03-01 0001929783 wok:BaimingYuMember 2022-03-01 2022-03-01 0001929783 wok:LiweiZhangMember 2022-03-01 2022-03-01 0001929783 wok:PermanentResidenceCertificateSubsidiariesMember 2022-03-01 2022-03-01 0001929783 wok:PermanentResidenceCertificateSubsidiariesMember us-gaap:CommonStockMember 2022-03-01 2022-03-01 0001929783 wok:PermanentResidenceCertificateSubsidiariesMember 2022-03-01 0001929783 wok:HangzhouMember 2022-05-06 2022-05-06 0001929783 wok:HangzhouHanshiMedicalEquipmentCoLtdMember 2022-02-21 0001929783 wok:ShanghaiSaitumofeiMember 2022-07-27 0001929783 2022-07-27 0001929783 2024-05-24 0001929783 wok:ShanghaiSaitumofeiMember 2024-05-24 0001929783 wok:HuangshanFundMember 2024-05-24 2024-05-24 0001929783 wok:ShanghaiSaitumofeiMember 2026-03-03 0001929783 wok:ShanghaiSaitumofeiMember 2026-03-03 2026-03-03 0001929783 wok:WorkBVIMember 2025-10-01 2026-03-31 0001929783 wok:WorkMedicalTechnologyMember 2025-10-01 2026-03-31 0001929783 wok:WorkRWATECHLIMITEDMember 2025-10-01 2026-03-31 0001929783 wok:WFOEMember 2025-10-01 2026-03-31 0001929783 wok:WorkHangzhouMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouShanyouMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouHanshiMember 2025-10-01 2026-03-31 0001929783 wok:ShanghaiSaitumofeiMedicalTreatmentTechnologyCoLtdShanghaiSaitumofeiMember 2025-10-01 2026-03-31 0001929783 wok:HunanSaitumofeiMedicalTreatmentTechnologyCoLtdHunanSaitumofeiMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouWoliMedicalTreatmentTechnologyCoLtdHangzhouWoliMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouYoushunheTechnologyCoLtdHangzhouYoushunheMember 2025-10-01 2026-03-31 0001929783 wok:HuangshanSaitumofeiMedicalTreatmentTechnologyCoLtdMember 2025-10-01 2026-03-31 0001929783 wok:WORKMedicalTechnologyGroupLTDMember 2026-03-31 0001929783 us-gaap:AccountsReceivableMember 2026-03-31 0001929783 us-gaap:AccountsReceivableMember 2025-09-30 0001929783 us-gaap:GeographicDistributionDomesticMember 2025-10-01 2026-03-31 0001929783 us-gaap:GeographicDistributionDomesticMember 2024-10-01 2025-03-31 0001929783 us-gaap:GeographicDistributionForeignMember 2025-10-01 2026-03-31 0001929783 us-gaap:GeographicDistributionForeignMember 2024-10-01 2025-03-31 0001929783 wok:MedicalDevicesOtherThanMasksMember 2025-10-01 2026-03-31 0001929783 wok:MedicalDevicesOtherThanMasksMember 2024-10-01 2025-03-31 0001929783 wok:MasksMember 2025-10-01 2026-03-31 0001929783 wok:MasksMember 2024-10-01 2025-03-31 0001929783 wok:CommodityTradingMember 2025-10-01 2026-03-31 0001929783 wok:CommodityTradingMember 2024-10-01 2025-03-31 0001929783 wok:OthersRevenueProductMember 2025-10-01 2026-03-31 0001929783 wok:OthersRevenueProductMember 2024-10-01 2025-03-31 0001929783 us-gaap:AccountsReceivableMember 2025-10-01 2026-03-31 0001929783 us-gaap:AccountsReceivableMember 2024-10-01 2025-03-31 0001929783 wok:HangzhouWeishiMember 2025-09-30 0001929783 wok:HangzhouWeishiMember 2025-09-30 2025-09-30 0001929783 us-gaap:BuildingMember 2026-03-31 0001929783 us-gaap:BuildingMember 2025-09-30 0001929783 us-gaap:MachineryAndEquipmentMember 2026-03-31 0001929783 us-gaap:MachineryAndEquipmentMember 2025-09-30 0001929783 us-gaap:VehiclesMember 2026-03-31 0001929783 us-gaap:VehiclesMember 2025-09-30 0001929783 us-gaap:OfficeEquipmentMember 2026-03-31 0001929783 us-gaap:OfficeEquipmentMember 2025-09-30 0001929783 us-gaap:LeaseholdImprovementsMember 2026-03-31 0001929783 us-gaap:LeaseholdImprovementsMember 2025-09-30 0001929783 us-gaap:UseRightsMember 2026-03-31 0001929783 us-gaap:UseRightsMember 2025-09-30 0001929783 wok:DigitalFactoryOperationManagementSystemMember 2026-03-31 0001929783 wok:DigitalFactoryOperationManagementSystemMember 2025-09-30 0001929783 us-gaap:PatentsMember 2026-03-31 0001929783 us-gaap:PatentsMember 2025-09-30 0001929783 wok:MaskCustomizationSystemMember 2026-03-31 0001929783 wok:MaskCustomizationSystemMember 2025-09-30 0001929783 2026-02-28 0001929783 wok:PRCMember 2025-10-01 2026-03-31 0001929783 wok:PRCMember 2024-10-01 2025-03-31 0001929783 wok:BankOfJiangsuMember 2026-03-31 0001929783 wok:BankOfJiangsuMember 2025-10-01 2026-03-31 0001929783 wok:BankOfJiangsuMember 2025-03-31 0001929783 wok:BankOfJiangsuOneMember 2026-03-31 0001929783 wok:BankOfJiangsuOneMember 2025-10-01 2026-03-31 0001929783 wok:BankOfJiangsuOneMember 2025-03-31 0001929783 wok:BankOfJiangsuTwoMember 2025-10-01 2026-03-31 0001929783 wok:BankOfJiangsuTwoMember 2026-03-31 0001929783 wok:BankOfJiangsuTwoMember 2025-03-31 0001929783 wok:XiaoshanRuralCommercialBankMember 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankMember 2025-10-01 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankMember 2025-03-31 0001929783 wok:XiaoshanRuralCommercialBankOneMember 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankOneMember 2025-10-01 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankOneMember 2025-03-31 0001929783 wok:XiaoshanRuralCommercialBankTwoMember 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankTwoMember 2025-10-01 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankTwoMember 2025-03-31 0001929783 wok:XiaoshanRuralCommercialBankThreeMember 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankThreeMember 2025-10-01 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankThreeMember 2025-03-31 0001929783 wok:XiaoshanRuralCommercialBankFourMember 2025-10-01 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankFourMember 2026-03-31 0001929783 wok:XiaoshanRuralCommercialBankFourMember 2025-03-31 0001929783 wok:BaimingYuMember 2025-10-01 2026-03-31 0001929783 wok:LiweiZhangMember 2025-10-01 2026-03-31 0001929783 wok:HuiyuChuangguMember 2025-10-01 2026-03-31 0001929783 wok:ShuangWuMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouQingniuMedicalInstrumentCoLtdHangzhouQingniuMember 2025-10-01 2026-03-31 0001929783 wok:QijiaYuMember 2025-10-01 2026-03-31 0001929783 wok:EZGOTechnologiesLtdEZGOMember 2025-10-01 2026-03-31 0001929783 wok:HangzhouQingniuMember 2026-03-31 0001929783 wok:HangzhouQingniuMember 2025-09-30 0001929783 wok:HangzhouShuigeMember 2026-03-31 0001929783 wok:HangzhouShuigeMember 2025-09-30 0001929783 wok:HuiyuChuangguMember 2026-03-31 0001929783 wok:HuiyuChuangguMember 2025-09-30 0001929783 wok:ShuangWuMember 2026-03-31 0001929783 wok:ShuangWuMember 2025-09-30 0001929783 wok:QijiaYuMember 2026-03-31 0001929783 wok:QijiaYuMember 2025-09-30 0001929783 wok:EZGOTechnologiesLtdEZGOMember 2026-03-31 0001929783 wok:EZGOTechnologiesLtdEZGOMember 2025-09-30 0001929783 wok:BaimingYuMember 2026-03-31 0001929783 wok:BaimingYuMember 2025-09-30 0001929783 wok:LoanToHangzhouShuigeMember 2025-10-01 2026-03-31 0001929783 wok:LoanToHangzhouShuigeMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentFromHangzhouShuigeMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentFromHangzhouShuigeMember 2024-10-01 2025-03-31 0001929783 wok:SalesToHangzhouShuigeMember 2025-10-01 2026-03-31 0001929783 wok:SalesToHangzhouShuigeMember 2024-10-01 2025-03-31 0001929783 wok:LoanFromHangzhouShuigeMember 2025-10-01 2026-03-31 0001929783 wok:LoanFromHangzhouShuigeMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentToHangzhouShuigeMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentToHangzhouShuigeMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentToBaimingYuMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentToBaimingYuMember 2024-10-01 2025-03-31 0001929783 wok:LoanToBaimingYuMember 2025-10-01 2026-03-31 0001929783 wok:LoanToBaimingYuMember 2024-10-01 2025-03-31 0001929783 wok:SalesToBaimingYuMember 2025-10-01 2026-03-31 0001929783 wok:SalesToBaimingYuMember 2024-10-01 2025-03-31 0001929783 wok:SalesToHangzhouQingniuMember 2025-10-01 2026-03-31 0001929783 wok:SalesToHangzhouQingniuMember 2024-10-01 2025-03-31 0001929783 wok:LoanToHangzhouQingniuMember 2025-10-01 2026-03-31 0001929783 wok:LoanToHangzhouQingniuMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentFromHangzhouQingniuMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentFromHangzhouQingniuMember 2024-10-01 2025-03-31 0001929783 wok:PurchaseFromHangzhouQingniuMember 2025-10-01 2026-03-31 0001929783 wok:PurchaseFromHangzhouQingniuMember 2024-10-01 2025-03-31 0001929783 wok:LoanToShuangWuMember 2025-10-01 2026-03-31 0001929783 wok:LoanToShuangWuMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentFromShuangWuMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentFromShuangWuMember 2024-10-01 2025-03-31 0001929783 wok:LoanFromShuangWuMember 2025-10-01 2026-03-31 0001929783 wok:LoanFromShuangWuMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentToShuangWuMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentToShuangWuMember 2024-10-01 2025-03-31 0001929783 wok:AdvanceToHuiyuChuangguMember 2025-10-01 2026-03-31 0001929783 wok:AdvanceToHuiyuChuangguMember 2024-10-01 2025-03-31 0001929783 wok:PaymentOfEquityTransferConsiderationOnBehalfOfTheCompanyMember 2025-10-01 2026-03-31 0001929783 wok:PaymentOfEquityTransferConsiderationOnBehalfOfTheCompanyMember 2024-10-01 2025-03-31 0001929783 wok:RepaymentToHuiyuChuangguForIPOCostsPaidOnBehalfOfTheGroupMember 2025-10-01 2026-03-31 0001929783 wok:RepaymentToHuiyuChuangguForIPOCostsPaidOnBehalfOfTheGroupMember 2024-10-01 2025-03-31 0001929783 wok:AdvanceToQijiaYuMember 2025-10-01 2026-03-31 0001929783 wok:AdvanceToQijiaYuMember 2024-10-01 2025-03-31 0001929783 wok:ReimbursementFromQijiaYuMember 2025-10-01 2026-03-31 0001929783 wok:ReimbursementFromQijiaYuMember 2024-10-01 2025-03-31 0001929783 wok:LoanToEZGOMember 2025-10-01 2026-03-31 0001929783 wok:LoanToEZGOMember 2024-10-01 2025-03-31 0001929783 wok:InterestReceivableFromEZGOMember 2025-10-01 2026-03-31 0001929783 wok:InterestReceivableFromEZGOMember 2024-10-01 2025-03-31 0001929783 us-gaap:CommonStockMember 2026-03-31 0001929783 2023-04-06 2023-04-06 0001929783 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2023-04-06 0001929783 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2023-04-06 2023-04-06 0001929783 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember us-gaap:CommonStockMember 2023-04-06 0001929783 us-gaap:CommonStockMember 2023-04-06 0001929783 2026-08-26 2026-08-26 0001929783 us-gaap:OverAllotmentOptionMember 2026-08-26 2026-08-26 0001929783 us-gaap:OverAllotmentOptionMember 2026-08-26 0001929783 us-gaap:IPOMember 2026-08-26 2026-08-26 0001929783 srt:CumulativeEffectPeriodOfAdoptionAdjustedBalanceMember 2025-02-05 0001929783 wok:RedesignatedShareMember 2025-02-05 0001929783 us-gaap:CommonClassAMember wok:ReclassifiedShareMember 2025-02-05 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember wok:ReclassifiedShareMember 2025-02-05 0001929783 us-gaap:CommonClassAMember wok:ReclassifiedShareMember 2025-02-05 2025-02-05 0001929783 us-gaap:CommonClassBMember wok:ReclassifiedShareMember 2025-02-05 0001929783 us-gaap:CommonClassBMember 2025-02-05 2025-02-05 0001929783 us-gaap:CommonClassBMember wok:RedesignationSharesMember 2025-04-08 0001929783 2025-05-22 2025-05-22 0001929783 us-gaap:CommonClassAMember 2025-05-22 2025-05-22 0001929783 wok:SeriesAWarrantsMember 2025-05-22 0001929783 wok:SeriesAWarrantsMember us-gaap:CommonClassAMember 2025-05-22 0001929783 wok:SeriesBWarrantsMember 2025-05-22 0001929783 wok:SeriesBWarrantsMember us-gaap:CommonClassAMember 2025-05-22 0001929783 2025-05-22 0001929783 wok:SeriesAWarrantsMember 2026-03-31 0001929783 wok:SeriesBWarrantsMember 2026-03-31 0001929783 wok:SeriesBWarrantsMember us-gaap:CommonClassAMember 2026-03-31 0001929783 us-gaap:CommonClassAMember wok:SecuritiesPurchaseAgreementMember 2025-09-25 0001929783 wok:PreFundedWarrantsMember 2025-09-25 0001929783 us-gaap:CommonClassAMember 2025-09-25 0001929783 2025-09-26 2025-09-26 0001929783 srt:MinimumMember 2026-03-31 0001929783 srt:MaximumMember 2026-03-31 0001929783 wok:PreFundedWarrantsMember 2026-03-31 0001929783 srt:MinimumMember 2025-09-12 0001929783 wok:WORKMedicalTechnologyGroupLTDMember us-gaap:CommonClassAMember 2025-09-12 0001929783 wok:WORKMedicalTechnologyGroupLTDMember us-gaap:CommonClassBMember 2025-09-12 0001929783 srt:MaximumMember 2025-09-12 0001929783 srt:MinimumMember 2025-09-29 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember wok:RegisteredDirectOfferingMember 2025-09-29 0001929783 us-gaap:CommonClassAMember wok:RegisteredDirectOfferingMember 2025-09-29 0001929783 us-gaap:CommonClassBMember wok:RegisteredDirectOfferingMember 2025-09-29 0001929783 srt:MaximumMember 2025-09-29 0001929783 us-gaap:CommonClassAMember 2025-09-29 2025-09-29 0001929783 2025-09-29 0001929783 us-gaap:CommonClassBMember 2025-09-29 2025-09-29 0001929783 us-gaap:CommonClassBMember 2025-09-29 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-11-20 0001929783 2025-11-20 0001929783 2025-11-20 2025-11-20 0001929783 wok:SalesAgreementMember 2025-10-01 2026-03-31 0001929783 srt:ScenarioForecastMember 2026-08-29 0001929783 2025-11-07 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-11-07 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-11-07 0001929783 us-gaap:CommonClassAMember 2025-11-07 0001929783 wok:ClassBOrdinarySharesMember us-gaap:CommonStockMember 2025-11-07 0001929783 us-gaap:CommonClassBMember 2025-11-07 0001929783 us-gaap:CommonClassAMember 2025-11-29 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2025-11-29 0001929783 us-gaap:CommonClassBMember 2025-11-29 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-11-29 0001929783 us-gaap:CommonClassBMember 2025-12-30 2025-12-30 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2025-12-30 0001929783 us-gaap:CommonClassAMember wok:SubscriptionReceivableMember 2026-03-31 0001929783 us-gaap:CommonClassBMember wok:SubscriptionReceivableMember 2025-09-30 0001929783 srt:MinimumMember 2025-10-01 2026-03-31 0001929783 srt:MaximumMember 2025-10-01 2026-03-31 0001929783 wok:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-10-01 2026-03-31 0001929783 wok:CustomerAMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2025-09-30 0001929783 wok:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-10-01 2026-03-31 0001929783 wok:CustomerBMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2025-09-30 0001929783 wok:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-10-01 2026-03-31 0001929783 wok:CustomerCMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2025-09-30 0001929783 wok:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2025-10-01 2026-03-31 0001929783 wok:CustomerDMember us-gaap:AccountsReceivableMember us-gaap:CustomerConcentrationRiskMember 2024-10-01 2025-09-30 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierAMember 2025-10-01 2026-03-31 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierAMember 2024-10-01 2025-03-31 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierBMember 2025-10-01 2026-03-31 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierBMember 2024-10-01 2025-03-31 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierCMember 2025-10-01 2026-03-31 0001929783 wok:PurchaseMember us-gaap:SupplierConcentrationRiskMember wok:SupplierCMember 2024-10-01 2025-03-31 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierDMember 2025-10-01 2026-03-31 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierDMember 2024-10-01 2025-09-30 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierEMember 2025-10-01 2026-03-31 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierEMember 2024-10-01 2025-09-30 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierFMember 2025-10-01 2026-03-31 0001929783 wok:AdvanceToSuppliersMember us-gaap:SupplierConcentrationRiskMember wok:SupplierFMember 2024-10-01 2025-09-30 0001929783 2025-10-01 2025-10-01 0001929783 2026-04-23 0001929783 2026-04-23 2026-04-23 0001929783 2026-05-13 2026-05-13 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-05-13 0001929783 us-gaap:CommonClassBMember 2026-05-13 2026-05-13 0001929783 us-gaap:CommonClassBMember 2026-05-13 0001929783 us-gaap:CommonClassAMember 2026-05-13 2026-05-13 0001929783 us-gaap:CommonClassAMember us-gaap:CommonStockMember 2026-05-13 2026-05-13 0001929783 wok:ClassBOrdinarySharesMember 2026-05-13 0001929783 us-gaap:CommonClassBMember us-gaap:CommonStockMember 2026-05-13 2026-05-13 0001929783 wok:ClassBOrdinarySharesMember us-gaap:CommonStockMember 2026-05-13 iso4217:USD iso4217:USD shares shares pure iso4217:CNY 6-K 2026 001-42256 WORK Medical Technology Group LTD

3253520

4088599

1959687

615838

1928279

2455477

3039738

10786334

6665932

1228095

4745498

1280790

21592654

20455133

16674502

10587852

953684

959116

23788

26060

913909

8150969

26716852

12701123

48309506

33156256

6596115

6391347

1636149

1724551

495338

402407

7028

12772

6551373

2932166

13917

6743

517547

501480

15817467

11971466

1189

1303

12771

18756

13960

20059

15831427

11991525

0.001

160000000

16238

500

48000

0.001

40000000

1008

1000000

3796

6250

27944153

13043402

899731 899731

1548480

4958991

-262105

-608729

30124026

18338941

2354053

2825790

32478079

21164731

48309506

33156256

5402554

4505693

10203

37892

4370582

2957449

5980

23839

1036195

1562297

954612

1004786

3520028

1870797

98670

253082

4573310

3128665

35752

4548

117902

286827

120217

1536455

-13288

191016

24779

1445192

-3512336

-121176

-153

-91751

50969

-3461214

-29425

-50703

-42581

-3410511

13156

-392830

323982

-3068384

-353407

-4497

-115044

-3063887

-238363

1711

-1993.25

901.59

7296

-6250

6617596

899731

6076018

-408465

13185926

2884447

16070373

7296

-15

-7296

13156

-42581

-29425

251519

72463

323982

7296

-6250

6617596

899731

6089174

-659984

12947563

2769403

15716966

48000

3796

-6250

13043402

899731

4958991

-608729

18338941

2825790

21164731

16142 8071070 9029901 17100971 17100971

150

-155

1000 500000 500000 500000 -8119204 -503800 8623004

-3410511

-50703

-3461214

2751999

467240

3219239

-346624

-46206

-392830

16238

1008

-6250

27944153

899731

1548480

-262105

30124026

2354053

32478079

-9907075

-2797030

3664875

238680

758

467168

-100000 -1054772 -3095268 -983941 1287844 2518170

-4516769

1762717

17100971

500000

428198

5808486

-428198

-5808486

-221898 513729 380863

526707

364329

5200000

1434884

-3804709

13783284

-3526684

-194519

-841

-835079

-4561838

4088599

6557605

3253520

1995767

8082

117344

271878

28375

8100000

2022-03-01

2000000

91942

0.95

0.0335

0.0165

0.50

0.05

0.45

0.60

The unaudited condensed consolidated financial statements reflect the activities of the Group and each of the following entities: <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="border-bottom: black 1.5pt solid; text-align: left; width: 22%">Name</td> <td style="width: 1%; text-align: center"> </td> <td style="text-align: center; width: 23%; border-bottom: black 1.5pt solid">Date of incorporation/acquisition</td> <td style="width: 1%; text-align: center"> </td> <td style="text-align: center; width: 17%; border-bottom: black 1.5pt solid">Place of incorporation</td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; text-align: center; width: 17%">Percentage of effective ownership</td> <td style="width: 1%; text-align: center"> </td> <td style="border-bottom: black 1.5pt solid; width: 17%; text-align: center">Principal activities</td></tr> <tr> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt">Subsidiaries</td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: bottom"> </td> <td style="vertical-align: bottom; text-align: center"> </td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-indent: -9pt">Work BVI</td> <td style="text-align: center"> </td> <td style="text-align: center">March 15, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">British Virgin Islands (“BVI”)</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Work Cayman</td> <td style="text-align: center"> </td> <td style="text-align: center">Investment holding</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">Work Medical Technology</td> <td style="text-align: center"> </td> <td style="text-align: center">April 19, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">Hong Kong</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Work BVI</td> <td style="text-align: center"> </td> <td style="text-align: center">Investment holding</td></tr> <tr style="background-color: rgb(204,238,255)"> <td style="vertical-align: top; padding-left: 9pt; text-indent: -9pt">Work RWA TECH LIMITED</td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top; text-align: center">September 2, 2025</td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top; text-align: center">Hong Kong</td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top; text-align: center">100% owned by Work Medical Technology</td> <td style="vertical-align: bottom; text-align: center"> </td> <td style="vertical-align: top; text-align: center">Investment holding</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">WFOE</td> <td style="text-align: center"> </td> <td style="text-align: center">April 28, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Work Medical Technology</td> <td style="text-align: center"> </td> <td style="text-align: center">Investment holding</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-indent: -9pt">Work Hangzhou</td> <td style="text-align: center"> </td> <td style="text-align: center">November 10, 2021</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Work Age</td> <td style="text-align: center"> </td> <td style="text-align: center">Investment holding</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">Hangzhou Shanyou</td> <td style="text-align: center"> </td> <td style="text-align: center">April 29, 2002</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">95% owned by Work Hangzhou</td> <td style="text-align: center"> </td> <td style="text-align: center">Produce and sale of medical consumables</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-indent: -9pt">Hangzhou Hanshi</td> <td style="text-align: center"> </td> <td style="text-align: center">July 22, 2019</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">60% owned by Hangzhou Shanyou</td> <td style="text-align: center"> </td> <td style="text-align: center">Sale of medical consumables</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">Shanghai Saitumofei Medical Treatment Technology Co., Ltd. (“Shanghai Saitumofei”)*</td> <td style="text-align: center"> </td> <td style="text-align: center">July 27, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">57.5317% owned by Work Hangzhou</td> <td style="text-align: center"> </td> <td style="text-align: center">Sale of medical consumable</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-indent: -9pt">Hunan Saitumofei Medical Treatment Technology Co., Ltd (“Hunan Saitumofei”)</td> <td style="text-align: center"> </td> <td style="text-align: center">July 27, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Shanghai Saitumofei</td> <td style="text-align: center"> </td> <td style="text-align: center">Sale of medical consumables</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">Hangzhou Woli Medical Treatment Technology Co., Ltd (“Hangzhou Woli”)</td> <td style="text-align: center"> </td> <td style="text-align: center">July 22, 2022</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Work Hangzhou</td> <td style="text-align: center"> </td> <td style="text-align: center">Sale of medical consumables</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td style="padding-left: 9pt; text-indent: -9pt">Hangzhou Youshunhe Technology Co., Ltd. (“Hangzhou Youshunhe”)</td> <td style="text-align: center"> </td> <td style="text-align: center">February 27, 2023</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">51% owned by Hangzhou Shanyou</td> <td style="text-align: center"> </td> <td style="text-align: center">Sale of medical consumables</td></tr> <tr style="vertical-align: top; "> <td style="padding-left: 9pt; text-indent: -9pt">Huangshan Saitumofei Medical Treatment Technology Co., Ltd.</td> <td style="text-align: center"> </td> <td style="text-align: center">April 30, 2024</td> <td style="text-align: center"> </td> <td style="text-align: center">PRC</td> <td style="text-align: center"> </td> <td style="text-align: center">100% owned by Shanghai Saitumofei</td> <td style="text-align: center"> </td> <td style="text-align: center">Research and development</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">On July 27, 2022, Work Hangzhou acquired 51% of the shares of Shanghai Saitumofei for a cash consideration of RMB100,000. Since then, Shanghai Saitumofei has become a subsidiary of the Group.</td> </tr></table> On May 24, 2024, Work Hangzhou and the other original shareholders of Shanghai Saitumofei (collectively, the “Original Shareholders”) entered into a Capital Injection Agreement with Tunxi District Huangshan City Leading Industry Incubation Fund Ltd. (“Huangshan Fund”). According to the agreement, Huangshan Fund agreed to invest RMB20 million in cash to obtain 13.33% newly issued shares of Shanghai Saitumofei. Following the capital investment by Huangshan Fund, the Group’s ownership interest in Shanghai Saitumofei was diluted to 44.2017%. However, on May 24, 2024, the Original Shareholders entered into a concerted action agreement (the “Concerted Action Agreement”), to ensure that the Group retains majority voting rights (collectively 86.67%) in Shanghai Saitumofei. Under the Concerted Action Agreement, if the Original Shareholders cannot reach a consensus, Work Hangzhou’s opinion shall prevail. The Concerted Action Agreement has no fixed term and is irrevocable unless all parties consent unanimously. As a result, the Group is still required to consolidate Shanghai Saitumofei in the reporting entity in the scope of ASC 810 Consolidation.

2022-03-15

British Virgin Islands (“BVI”)

Investment holding

2022-04-19

Hong Kong

Investment holding

2025-09-02

Hong Kong

Investment holding

2022-04-28

PRC

Investment holding

2021-11-10

PRC

Investment holding

2002-04-29

PRC

0.95

Produce and sale of medical consumables

2019-07-22

PRC

0.60

Sale of medical consumables

2022-07-27

PRC

0.575317

Sale of medical consumable

2022-07-27

PRC

Sale of medical consumables

2022-07-22

PRC

Sale of medical consumables

2023-02-27

PRC

0.51

Sale of medical consumables

2024-04-30

PRC

Research and development

0.51

100000

20000000

0.1333

0.442017

0.8667

0.1333

22200000

3220000

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">2.</td><td style="text-align: justify">SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(a)</td><td style="text-align: justify">Basis of presentation and principles of consolidation</td> </tr></table> The accompanying unaudited condensed consolidated financial statements are prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”) and pursuant to the rules and regulations of the Securities and Exchange Commission (the “SEC”). The accompanying unaudited condensed consolidated financial statements include the unaudited condensed consolidated financial statements of the Company and its subsidiaries. Certain information and footnote disclosures normally included in financial statements prepared in accordance with U.S. GAAP have been condensed or omitted. The accompanying unaudited condensed consolidated financial statements should be read in conjunction with the financial statements and notes thereto included in the Company’s September 30, 2025 audited financial statements. The results of operations for the period ended March 31, 2026 are not necessarily indicative of the operating results for the full year. All inter-company balances and transactions are eliminated upon consolidation. For consolidated subsidiaries where the Group’s ownership in the subsidiary is less than 100%, the equity interest not held by the Group is shown as noncontrolling interests. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(b)</td><td style="text-align: justify">Accounts receivable, net</td> </tr></table> Accounts receivable are stated at the original amount less an allowance for credit losses. Accounts receivable are recognized in the period when the Group has provided goods to its customers and when its right to consideration is unconditional. On October 1, 2023, the Group adopted ASU 2016-13, “Financial Instruments - Credit Losses (Accounting Standards Codification (“ASC”) Topic 326): Measurement on Credit Losses on Financial Instruments,” including certain subsequent amendments, transitional guidance and other interpretive guidance within ASU 2018-19, ASU 2019-04, ASU 2019-05, ASU 2019-11, ASU 2020-02 and ASU 2020-03 (collectively, including ASU 2016-13, “ASC 326”). ASC 326 introduces an approach based on expected losses to estimate the allowance for doubtful accounts, which replaces the previous incurred loss impairment model. The Group’s estimation of allowance for credit losses considers factors such as historical credit loss experience, age of receivable balances, subsequent collection, current market conditions, reasonable and supportable forecasts of future economic conditions, as well as an assessment of receivables due from specific identifiable counterparties to determine whether these receivables are considered at risk or uncollectible. The Group evaluates its accounts receivable for expected credit losses on a regular basis. The Group maintains an estimated allowance for credit losses to reduce its accounts receivable to the amount that it believes will be collected. The Group considers factors in assessing the collectability of its receivables, such as the age of the amounts due, the customer’s payment history, creditworthiness and other specific circumstances related to the accounts. The Group adjusts the allowance percentage periodically when there are significant differences between estimated bad debts and actual bad debts. If there is strong evidence indicating that the accounts receivable is likely to be unrecoverable, the Group also makes specific allowance in the period in which a loss is determined to be probable. Accounts receivable balances are written off after all collection efforts have been exhausted.<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(c)</td> <td style="text-align: justify">Advance to suppliers</td></tr> </table> Advance to suppliers refers to advances for purchase of materials and trading products, which is applied against accounts payable when the materials or trading products are received. The Group reviews a supplier’s credit history and background information before advancing a payment. If the financial condition of its suppliers were to deteriorate, resulting in an impairment of their ability to deliver goods or provide services, the Group would provide allowance for such amount in the period when it is considered impaired. Advance to suppliers as of March 31, 2026 and September 30, 2025 primarily consisted of prepayments for purchasing raw materials and trading products. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(d)</td> <td style="text-align: justify">Long term investments</td></tr> </table> Long-term investments are the Group’s equity investments in privately held companies accounted for equity method. Equity investments are comprised of investments in privately held companies. The Group uses the equity method to account for an equity investment over which it has the ability to exert significant influence but does not otherwise have control. The Group records equity method investments at the cost of acquisition, plus the Group’s share in undistributed earnings and losses since acquisition. For equity investments over which the Group does not have significant influence or control, the cost method of accounting is used. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(e)</td> <td style="text-align: justify">Government subsidies</td></tr> </table> Government subsidies are recognized as other income when received and all the conditions for their receipt have been met. The government subsidies were paid by cash and have no defined rules and regulations to govern the criteria necessary for the Group to enjoy the benefits. For the six months ended March 31, 2026 and 2025, the Group received government subsidies of $120,217 and $1,536,455, respectively. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(f)</td><td style="text-align: justify">Revenue recognition</td> </tr></table> The Group recognizes revenues pursuant to ASC 606, Revenue from Contracts with Customers (“ASC 606”). In accordance with ASC 606, the Group recognizes revenue to depict the transfer of promised services to customers in an amount that reflects the consideration to which the Group expects to receive in exchange for those services, reduced by value-added tax (“VAT”). Net revenues are presented net of tax and surcharges. The following five steps are applied to achieve that core principle: <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0.25in"></td><td style="width: 0.5in; text-align: left">Step 1: </td><td style="text-align: justify">Identify the contract with the customer</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.5in">Step 2: </td> <td style="text-align: justify">Identify the performance obligations in the contract</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.5in">Step 3:</td> <td style="text-align: justify">Determine the transaction price</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.5in">Step 4: </td> <td style="text-align: justify">Allocate the transaction price to the performance obligations in the contract</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0.25in"> </td> <td style="width: 0.5in">Step 5:</td> <td style="text-align: justify">Recognize revenue when the company satisfies a performance obligation</td></tr> </table> Revenue from sales of self-manufactured masks and medical devices The Group sells products to different distributor customers and direct-end user customers, primarily of sales of self-manufactured masks and medical devices. The Group does not accept returns of products or offer refunds for its customers after the expiration of quality objection periods. The Group usually offers a seven-day quality objection period and any quality deficiencies are determined by the testing of a third-party institution. The Group grants credit sales for customers and the credit period varies among different customers. The Group normally grants the customers 30 to 180 days to complete their payments after the credit sales, and the length of the credit period is dependent on the customer’s creditworthiness and its transaction experience with the Group. The Group makes its judgment taking all of the facts and circumstances into account, including the PRC subsidiaries’ customary business practices and the knowledge of the customer, in determining whether it is probable that the PRC subsidiaries will collect substantially all of the consideration to which they will be entitled in exchange for the goods or services that the PRC subsidiaries expect to transfer to the customer. The Group identifies one performance obligation in this business, which is to transfer control of a product to a distributor customer or direct-end user customer upon delivery of the product to the designated place. The revenue is recognized at a point in time when the Group satisfies the performance obligation by transferring the control of the promised product to distributor customers or direct-end user customers. The Group presents the revenue generated from its sales of products on a gross basis as the Group acts as a principal. Revenue from commodity trading The Group identifies one performance obligation in commodity trading, which is to transfer control of a product to a customer upon delivery of the product to the designated place. Revenue from commodity trading is recognized on a net basis or gross basis based on whether the Group arranges the provision of products through third parties and control the specified products provided by the third parties before that products are transferred to the customers. The revenue is recognized at a point in time when the Group satisfies performance obligations by arranging the transfer of a promised product to a customer. When the Group acted as an agent, the revenue is measured at fixed consideration which is determined as the difference between the sales price that the Group expects to receive in exchange for arranging promised products to the customer and the settlement price with the third-party suppliers. When the Group acted as a principal, the revenue is measured at fixed consideration which is the sales price that the Group expects to receive in exchange for arranging promised products. Shipping and handling activities are considered to be fulfilment activities rather than promised services and are not, therefore, considered to be separate performance obligations. The Group’s sales terms provide no right of return outside of a standard quality policy and returns are generally not significant. Geographic information The following table disaggregates the Group’s revenue by geographic market for the six months ended March 31, 2026 and 2025: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">China domestic market</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,278,052</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">3,829,374</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Overseas market</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,134,705</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">714,211</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Net revenue</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">5,412,757</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">4,543,585</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>Revenue by product categories The following table disaggregates the Group’s revenue product categories for the six months ended March 31, 2026 and 2025: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-indent: -10pt; padding-left: 10pt">Medical devices(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,958,295</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,196,880</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -10pt; padding-left: 10pt">Masks</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">427,861</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">309,962</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Commodity trading</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">21,929</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">36,743</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Others</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">4,672</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Net revenue</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">5,412,757</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">4,543,585</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Medical devices are mainly anesthesia and respiratory consumables.</td> </tr></table> Contract balances Payment terms are established on the Group’s pre-established credit requirements based upon an evaluation of customers’ credit. Contract assets are recognized within the related accounts receivable. The contract liabilities consist of deferred revenue, which represents the billings or cash received for goods in advance of revenue recognition and is recognized as revenue when all the Group’s revenue recognition criteria are met. The Group’s deferred revenue was $495,338 and $402,407 as of March 31, 2026 and September 30, 2025, respectively. During the six months ended March 31, 2026 and 2025, the Group recognized $341,526 and $151,394 that was included in deferred revenue balance at September 30, 2025 and 2024, respectively. Other than deferred revenue, the Group had no other material contract assets, contract liabilities or deferred contract costs recorded on its consolidated balance sheets as of March 31, 2026 and September 30, 2025. Contract costs The Group applied a practical expedient to expense costs as incurred for costs to obtain a contract with a customer when the amortization period would have been one year or less. For the six months ended March 31, 2026 and 2025, the Group did not have any significant incremental costs of obtaining contracts with customers incurred and/or costs incurred in fulfilling contracts with customers within the scope of ASC Topic 606, that shall be recognized as an asset and amortized to expenses in a pattern that matches the timing of the revenue recognition of the related contract. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(g)</td><td style="text-align: justify">Recent accounting pronouncements</td> </tr></table> The Company is an “emerging growth company” (“EGC”) as defined in the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”). Under the JOBS Act, EGCs can delay adopting new or revised accounting standards issued subsequent to the enactment of the JOBS Act until such time as those standards apply to private companies. In March 2025, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update 2025-02 “Liabilities (405): Amendments to SEC Paragraphs Pursuant to SEC Staff Accounting Bulletin No. 122” (“ASU 2025-02”), which amends the Accounting Standards Codification to remove the text of SEC Staff Accounting Bulletin (“SAB”) 121 “Accounting for Obligations to Safeguard Crypto- Assets an Entity Holds for its Platform Users” as it has been rescinded by the issuance of SAB 122. ASU 2025-02 is effective immediately and is not expected to have an impact on the Group’s financial statements.In July 2025, the FASB issued ASU 2025-05, “Financial Instruments — Credit Losses (Topic 326): Measurement of Credit Losses for Accounts Receivable and Contract Assets,” which provides guidance for entities that apply the practical expedient and accounting policy election, if applicable, when estimating expected credit losses on current accounts receivable and/or current contract assets arising from transactions under Topic 606, including those assets acquired in a business combination accounted for under Topic 805. The amendments will be effective for annual reporting periods beginning after December 15, 2025, and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Group is currently evaluating the impact of the adoption of this guidance. In September 2025, the FASB issued ASU 2025-06, Intangibles -Goodwill and Other - Internal-Use Software (Subtopic 350-40): Targeted Improvements to the Accounting for Internal-Use Software (“ASU 2025-06”). The amendments modernize the recognition and disclosure framework for internal-use software costs, removing the previous “development stage” model and introducing a more judgment-based approach. ASU 2025-06 is effective for annual reporting periods beginning after December 15, 2027 and for interim reporting periods beginning in that fiscal year. The Group is currently evaluating the impact that this update will have on the consolidated financial statements. In September 2025, the FASB issued ASU 2025-07, Derivatives and Hedging (“Topic 815”) and Revenue from Contracts with Customers (“Topic 606”): Derivatives Scope Refinements and Scope Clarification for Share-Based Noncash Consideration from a Customer in a Revenue Contract (“ASU 2025-07”). ASU 2025-07, expands an existing scope exception under Topic 815 to exclude non-exchange-traded contracts where the underlying is based on the operations or activities specific to one of the contract parties. The Group is currently evaluating the impact that this update will have on the consolidated financial statements. In November 2025, the FASB issued ASU 2025-08, Financial Instruments—Credit Losses (“Topic 326”): Purchased Loans (“ASU 2025-08”). The amendments expand the population of acquired loans subject to the gross-up approach, treating non-credit-deteriorated loans (excluding credit cards) as “seasoned” if purchased at least 90 days after origination or acquired in a business combination. ASU 2025-08 is effective for annual reporting periods beginning after December 15, 2026 and interim reporting periods within those annual reporting periods. Early adoption is permitted. The Group is currently evaluating the impact that this update will have on the consolidated financial statements. In December 2025, the FASB issued ASU 2025-10, Government Grants (Topic 832): Accounting for Government Grants Received by Business Entities to establish authoritative guidance on the accounting for government grants received by business entities. This update is effective for annual and interim periods beginning after December 15, 2028, though early adoption is permitted. The Group is currently evaluating the impact that this update will have on the consolidated financial statements. In December 2025, the FASB issued ASU No. 2025-11, Interim Reporting (Topic 270): Narrow-Scope Improvements. The ASU clarifies interim disclosure requirements and the applicability of Topic 270. The objective of the amendments is to provide further clarity about the current interim disclosure requirements. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2027. Adoption of this ASU can be applied either a prospective or a retrospective approach. Early adoption is permitted. The Group is currently evaluating the impact that this update will have on the consolidated financial statements. In December 2025, the FASB issued ASU No. 2025-12, Codification Improvements. The ASU addresses thirty-three items, representing the changes to the Codification that (1) clarify, (2) correct errors, or (3) make minor improvements. Generally, the amendments in this Update are not intended to result in significant changes for most entities. The ASU is effective for interim reporting periods within annual reporting periods beginning after December 15, 2026. The adoption method of this ASU may vary, on an issue-by-issue basis. Early adoption is permitted. The Group is currently evaluating the impact that this update will have on the consolidated financial statements.

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(c)</td> <td style="text-align: justify">Advance to suppliers</td></tr> </table>Advance to suppliers refers to advances for purchase of materials and trading products, which is applied against accounts payable when the materials or trading products are received. The Group reviews a supplier’s credit history and background information before advancing a payment. If the financial condition of its suppliers were to deteriorate, resulting in an impairment of their ability to deliver goods or provide services, the Group would provide allowance for such amount in the period when it is considered impaired. Advance to suppliers as of March 31, 2026 and September 30, 2025 primarily consisted of prepayments for purchasing raw materials and trading products.

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(d)</td> <td style="text-align: justify">Long term investments</td></tr> </table>Long-term investments are the Group’s equity investments in privately held companies accounted for equity method.Equity investments are comprised of investments in privately held companies. The Group uses the equity method to account for an equity investment over which it has the ability to exert significant influence but does not otherwise have control. The Group records equity method investments at the cost of acquisition, plus the Group’s share in undistributed earnings and losses since acquisition. For equity investments over which the Group does not have significant influence or control, the cost method of accounting is used.

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 24px">(e)</td> <td style="text-align: justify">Government subsidies</td></tr> </table>Government subsidies are recognized as other income when received and all the conditions for their receipt have been met. The government subsidies were paid by cash and have no defined rules and regulations to govern the criteria necessary for the Group to enjoy the benefits.For the six months ended March 31, 2026 and 2025, the Group received government subsidies of $120,217 and $1,536,455, respectively.

120217

1536455

The following table disaggregates the Group’s revenue by geographic market for the six months ended March 31, 2026 and 2025: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">China domestic market</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,278,052</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">3,829,374</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Overseas market</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">1,134,705</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">714,211</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Net revenue</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">5,412,757</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">4,543,585</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

4278052

3829374

1134705

714211

5412757

4543585

The following table disaggregates the Group’s revenue product categories for the six months ended March 31, 2026 and 2025: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-indent: -10pt; padding-left: 10pt">Medical devices(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,958,295</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4,196,880</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -10pt; padding-left: 10pt">Masks</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">427,861</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">309,962</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Commodity trading</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">21,929</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">36,743</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Others</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">4,672</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Net revenue</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">5,412,757</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">4,543,585</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">Medical devices are mainly anesthesia and respiratory consumables.</td> </tr></table>

4958295

4196880

427861

309962

21929

36743

4672

5412757

4543585

495338

402407

341526

151394

P1Y

Accounts receivable, net consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: center"> </td> <td style="font-weight: bold; text-align: center"> </td> <td colspan="2" style="font-weight: bold; text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Accounts receivable</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">2,124,956</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">687,367</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Allowance for credit loss</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(165,269</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(71,529</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Accounts receivable, net</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,959,687</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">615,838</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

2124956

687367

165269

71529

1959687

615838

104251

32370

The Group recorded a reversal of credit loss of $14,213 and $81,026 for the six months ended March 31, 2026 and 2025, respectively.<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">For the Six Months Ended March 31, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Balance at the beginning of the period</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">71,529</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,003,799</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -10pt; padding-left: 10pt">Current period addition</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">104,251</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">32,370</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -10pt; padding-left: 10pt">Reversal</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(14,213</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(81,026</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Foreign currency translation adjustment</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,702</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(32,900</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at the end of the period</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">165,269</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">922,243</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table>

14213

81026

71529

1003799

104251 32370

-14213

-81026

3702 -32900

165269

922243

Inventories consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Work in progress</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">478,565</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">878,322</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Finished goods</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,468,567</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,404,946</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Raw materials</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">554,991</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">527,252</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Less: impairment</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">573,844</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">355,043</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Inventories, net</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,928,279</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,455,477</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

478565

878322

1468567

1404946

554991

527252

573844 355043

1928279

2455477

Impairment provided for the inventories was $306,964 and $62,892 for the six months ended March 31, 2026 and 2025, respectively. <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">For the Six Months Ended March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">For the Six Months Ended March 31, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Balance at the beginning of the period</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">355,043</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">251,642</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-indent: -10pt; padding-left: 10pt">Current period addition</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">306,964</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">62,892</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -10pt; padding-left: 10pt">Reduction</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(102,739</td> <td style="text-align: left">)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">(89,761</td> <td style="text-align: left">)</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Foreign currency translation adjustment</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">14,576</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">(8,196</td> <td style="padding-bottom: 1.5pt; text-align: left">)</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Balance at the end of the period</td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">573,844</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; text-align: left">$</td> <td style="border-bottom: Black 4pt double; text-align: right">216,577</td> <td style="padding-bottom: 2.5pt; text-align: left"> </td></tr> </table> 306964 62892 355043 251642 306964 62892

102739

89761

14576 -8196 573844 216577

Prepaid expenses and other current assets consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="text-align: center; padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="text-align: center; font-weight: bold"> </td> <td colspan="2" style="text-align: center; font-weight: bold">(Unaudited)</td> <td style="text-align: center; font-weight: bold"> </td> <td style="text-align: center"> </td> <td colspan="2" style="text-align: center"> </td> <td style="text-align: center"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Loans to third parties(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">111,598</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">1,048,082</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Prepaid expenses(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,534,572</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">190,782</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 1.5pt">Others(3)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">2,099,328</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">41,926</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left">Total prepaid expenses and other current assets, net</td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">4,745,498</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="padding-bottom: 2.5pt; font-weight: bold"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">1,280,790</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">In September 2025, the Company entered into agreements with Hangzhou Weishi Trading Co., Ltd. (“Hangzhou Weishi”), to lend up to RMB7,000,000 (approximately $983,284) to Hangzhou Weishi, with annualized interest rate at 4.00%, and due in September 2026. The Company has collected all the balance in February 2026. The balance as of March 31, 2026 mainly represented an interest-free loan to NEOLOGICS BIOSCIENCE INC.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">The balance represented the unamortized portion of prepayments made to certain service providers of the Group for their daily operations, which was expected to amortize over a period of less than 12 months.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">The balance as of March 31, 2026 mainly represented refundable equity investment prepayment of $2.0 million.</td> </tr></table>

111598

1048082

2534572

190782

-2099328 -41926

4745498

1280790

7000000

983284

0.04

P12M 2000000

Property, plant and equipment, net consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Property and buildings</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">17,674,164</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">11,464,247</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Machinery and equipment</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,842,792</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">5,304,738</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -10pt; padding-left: 10pt">Vehicle</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">193,164</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">187,476</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Office and electric equipment</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">156,961</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">151,449</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Buildings improvement</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">328,088</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">317,903</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Subtotal</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">24,195,169</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">17,425,813</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Less: impairment</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">930,819</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">901,923</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Less: accumulated depreciation</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">6,589,848</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">5,936,038</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Property, plant and equipment, net</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">16,674,502</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,587,852</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

17674164

11464247

5842792

5304738

193164

187476

156961

151449

328088

317903

24195169

17425813

930819 901923

6589848

5936038

16674502

10587852

2047875

6161206

470244

297541

Intangible assets, net consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Land use rights</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,034,998</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,002,869</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Digital factory operation management system</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">174,821</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">169,394</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -10pt; padding-left: 10pt">Patent</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">145,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">141,229</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Mask customization system</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">38,903</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">37,695</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-indent: -10pt; padding-left: 10pt">Subtotal</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: right">1,394,476</td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: right">1,351,187</td> <td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Less: accumulated amortization</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">440,792</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">392,071</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Intangible assets, net</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">953,684</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">959,116</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

1034998

1002869

174821

169394

145754

141229

38903

37695

1394476

1351187

440792

392071

953684

959116

35602

34160

The following table presents future amortization as of March 31, 2026: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: left"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">Amount</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; width: 88%">For the remainder of the year ending September 30, 2026</td><td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td><td style="width: 9%; text-align: right">36,160</td><td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; font-weight: bold; text-indent: -10pt; padding-left: 10pt">Year ending September 30,</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right"> </td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">2027</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">66,279</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">2028</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">55,560</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">2029</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,940</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">2030</td><td> </td> <td style="text-align: left"> </td><td style="text-align: right">46,501</td><td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Thereafter</td><td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td><td style="border-bottom: Black 1.5pt solid; text-align: right">702,244</td><td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 4pt"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">953,684</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

36160

66279

55560

46940

46501

702244

953684

As of March 31, 2026 and September 30, 2025, long-term investments consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td><td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td><td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td><td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td><td style="font-weight: bold"> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; text-align: left">Long-term investments:</td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="text-align: right"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Investments accounted for using the equity method</td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right">8,150,969</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td><td style="width: 1%; padding-bottom: 1.5pt"> </td> <td style="width: 1%; border-bottom: Black 1.5pt solid; text-align: left">$</td><td style="width: 9%; border-bottom: Black 1.5pt solid; text-align: right"> -</td><td style="width: 1%; padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="font-weight: bold; text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total long-term investments</td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">8,150,969</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td><td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td><td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">-</td><td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

8150969

0.30 81000

Accrued expenses and other liabilities consisted of the following: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: right"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Other taxes payable</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">2,061,258</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">1,975,064</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Property Purchase Payables(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,218,382</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Payroll payable</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">473,977</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">513,578</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Payable equity purchase consideration(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,414,530</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt; text-indent: -10pt; padding-left: 10pt">Other payable</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">383,226</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">443,524</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; padding-bottom: 2.5pt; text-indent: -10pt; padding-left: 10pt">Total accrued expenses and other liabilities</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,551,373</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">2,932,166</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">In February 2026, Work Hangzhou entered into a property purchase agreement with a third party, to purchase a building at a price of RMB 40.30 million ($5.84 million). The balance represented unpaid purchase price as of March 31, 2026, and approximately RMB 12.90 million ($1.88 million) has been paid subsequently.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">In February 2026, Work Hangzhou acquired 13.33% shares of Shanghai Saitumofei owned by Huangshan Fund at a consideration of RMB 22.2 million ($3.22 million). The balance represented unpaid purchase price as of March 31, 2026, which has been fully paid as of the date of this unaudited condensed consolidated financial statements.</td> </tr></table>

2061258 1975064 2218382

473977

513578

1414530

383226

443524

6551373

2932166

40300000 5840000 12900000 1880000

0.25

0.0001

0.7572

0.25

As of March 31, 2026 and September 30, 2025, summary of short-term bank borrowings is as follows: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="text-align: center"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="border-bottom: Black 1.5pt solid; text-align: center">Annual interest rate</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: center">Maturity date</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">March 31, 2026 (Unaudited)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 52%">Bank of Jiangsu</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: center"> </td> <td style="width: 9%; text-align: center">3.60%</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 11%; text-align: center">February 2027</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">434,909</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center">4.05%</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">February 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">421,408</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td> </td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center"> </td> <td style="text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: center">Subtotal</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td> <td style="font-weight: bold; text-align: right">434,909</td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left">$</td> <td style="font-weight: bold; text-align: right">421,408</td> <td style="font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Xiaoshan Rural Commercial Bank</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">3.60%</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center">August 2026</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,551,754</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,441,494</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Xiaoshan Rural Commercial Bank</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">3.60%</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center">August 2026</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,159,756</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,123,753</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Xiaoshan Rural Commercial Bank</td> <td> </td> <td style="text-align: center"> </td> <td style="text-align: center">3.60%</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: center">August 2026</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">724,848</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">702,346</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; padding-bottom: 1.5pt">Xiaoshan Rural Commercial Bank</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center">3.60%</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="text-align: center; padding-bottom: 1.5pt">July 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">724,848</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">702,346</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: center"> </td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="font-weight: bold; text-align: center; padding-bottom: 1.5pt">Subtotal</td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">6,161,206</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 1.5pt solid; font-weight: bold; text-align: right">5,969,939</td> <td style="padding-bottom: 1.5pt; font-weight: bold; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 4pt"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td> <td style="padding-bottom: 2.5pt; text-align: center"> </td> <td style="padding-bottom: 2.5pt; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="font-weight: bold; text-align: center; padding-bottom: 4pt">Total</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,596,115</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">6,391,347</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table>

0.036

February 2027

434909

0.0405

February 2026

421408

Subtotal

434909

421408

0.036

August 2026

3551754

3441494

0.036

August 2026

1159756

1123753

0.036

August 2026

724848

702346

0.036

July 2026

724848

702346

Subtotal

6161206

5969939

6596115

6391347

117902

286827

0.036

0.0417

<table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">12.</td><td style="text-align: justify">RELATED PARTY TRANSACTIONS</td> </tr></table> The following is a list of related parties which the Group has transactions with: <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="width: 5%; border-bottom: black 1.5pt solid">No.</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 46%; border-bottom: black 1.5pt solid; text-align: center">Name of Related Parties</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 47%; border-bottom: black 1.5pt solid; text-align: center">Relationship with the Group</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>a</td> <td style="white-space: nowrap"> </td> <td>Baiming Yu</td> <td style="white-space: nowrap"> </td> <td>COO, Director and a significant shareholder of the Group</td></tr> <tr style="vertical-align: top; "> <td>b</td> <td style="white-space: nowrap"> </td> <td>Huiyu Chuanggu (Hangzhou) Equity Investment Fund Co., Ltd. (“Huiyu Chuanggu”)</td> <td style="white-space: nowrap"> </td> <td>Shuang Wu acted as the executive director and owned 30% equity interests of this related party</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>c</td> <td style="white-space: nowrap"> </td> <td>Shuang Wu</td> <td style="white-space: nowrap"> </td> <td>CEO, Director, and Chairman of the Board of Directors</td></tr> <tr style="vertical-align: top; "> <td>d</td> <td style="white-space: nowrap"> </td> <td>Hangzhou Shuige Technology Co., Ltd (“Hangzhou Shuige”)</td> <td style="white-space: nowrap"> </td> <td>55% equity interests owned by Baiming Yu</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>e</td> <td style="white-space: nowrap"> </td> <td>Hangzhou Qingniu Medical Instrument Co., Ltd (“Hangzhou Qingniu”)</td> <td style="white-space: nowrap"> </td> <td>Owned by immediate family member of Baiming Yu</td></tr> <tr style="vertical-align: top; "> <td>f</td> <td style="white-space: nowrap"> </td> <td>Qijia Yu</td> <td style="white-space: nowrap"> </td> <td>Immediate family member of Baiming Yu</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>g</td> <td style="white-space: nowrap"> </td> <td>EZGO Technologies Ltd (“EZGO”)</td> <td style="white-space: nowrap"> </td> <td>A company significantly influenced by Shaung Wu in its management or operating policies</td></tr> </table> Amounts due from related parties Amounts due from related parties consisted of the following for the periods indicated: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Hangzhou Qingniu(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Hangzhou Shuige(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">19</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Huiyu Chuanggu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,474,926</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">15,276</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">9,310,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Qijia Yu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,943</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,404</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">EZGO(3)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,022,500</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,039,738</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,786,334</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The balance represents account receivables from related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">The balance represents advances made to the related parties for the Group’s daily operational purposes.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This balance represents a loan of $3,000,000 with an interest rate of 3% and will be matured on December 2026.</td> </tr></table>Amounts due to related parties Amounts due to related parties consisted of the following for the periods indicated: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Hangzhou Qingniu(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">7,028</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Baiming Yu(1)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,772</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,028</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,772</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The balance represents an advance from this related party for the Group’s daily operations, which is interest-free and has no fixed repayment term.</td> </tr></table> Related party transactions <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Nature</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2026 (Unaudited)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2025 (Unaudited)</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Loan to Hangzhou Shuige(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">107,872</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment from Hangzhou Shuige(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">436,336</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales to Hangzhou Shuige(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">185</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan from Hangzhou Shuige(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">428,198</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment to Hangzhou Shuige(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">428,198</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment to Baiming Yu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,978</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan to Baiming Yu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">161,853</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Sales to Baiming Yu(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,184</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales to Hangzhou Qingniu(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,203</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">34,708</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan to Hangzhou Qingniu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,383</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">74,681</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment from Hangzhou Qingniu(1&5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">98,490</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Purchase from Hangzhou Qingniu(6)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,254</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan to Shuang Wu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">92,885</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">628,294</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment from Shuang Wu(1&7)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,287,844</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,011,267</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan from Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">85,531</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">380,863</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment to Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">85,531</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">364,329</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advance to Huiyu Chuanggu(7)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">782,654</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Payment of equity transfer consideration on behalf of the Company(3)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">8,100,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment to Huiyu Chuanggu for IPO costs paid on behalf of the Group (2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,033,517</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Advance to Qijia Yu(4)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,074</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Reimbursement from Qijia Yu(4)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">492</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan to EZGO(8)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,000,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest receivable from EZGO(8)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">22,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">These consisted of the Group’s interest-free loans, which are due on demand, to the related parties for their daily operations and repayment from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">These consisted of the Group’s interest-free loans, which are due on demand, from the related parties for the Group’s daily operations or a portion of the IPO costs, including legal fees and accounting fees, and repayment to the related parties.</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This consisted of the equity transfer consideration paid by Shuang Wu on behalf of the Company.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">This consisted of the advances, which are interest-free and due on demand, made to the related parties for the Group’s daily operational purposes, and repayment and reimbursement from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">These consisted of the receivables for selling medical consumables to the related parties and repayment from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: justify">This consisted of the payable for purchase of materials from the related party.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: justify">These include: (i) repayments of borrowings from related parties for the Group’s daily operations; and (ii) prepayments for management services of financial administration, financial statement analysis, and financial planning advice.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(8)</td><td style="text-align: justify">These consisted of an interest-bearing loan to the related party and corresponding interests.</td> </tr></table>

The following is a list of related parties which the Group has transactions with: <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-collapse: collapse; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td style="width: 5%; border-bottom: black 1.5pt solid">No.</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 46%; border-bottom: black 1.5pt solid; text-align: center">Name of Related Parties</td> <td style="white-space: nowrap; width: 1%"> </td> <td style="width: 47%; border-bottom: black 1.5pt solid; text-align: center">Relationship with the Group</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>a</td> <td style="white-space: nowrap"> </td> <td>Baiming Yu</td> <td style="white-space: nowrap"> </td> <td>COO, Director and a significant shareholder of the Group</td></tr> <tr style="vertical-align: top; "> <td>b</td> <td style="white-space: nowrap"> </td> <td>Huiyu Chuanggu (Hangzhou) Equity Investment Fund Co., Ltd. (“Huiyu Chuanggu”)</td> <td style="white-space: nowrap"> </td> <td>Shuang Wu acted as the executive director and owned 30% equity interests of this related party</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>c</td> <td style="white-space: nowrap"> </td> <td>Shuang Wu</td> <td style="white-space: nowrap"> </td> <td>CEO, Director, and Chairman of the Board of Directors</td></tr> <tr style="vertical-align: top; "> <td>d</td> <td style="white-space: nowrap"> </td> <td>Hangzhou Shuige Technology Co., Ltd (“Hangzhou Shuige”)</td> <td style="white-space: nowrap"> </td> <td>55% equity interests owned by Baiming Yu</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>e</td> <td style="white-space: nowrap"> </td> <td>Hangzhou Qingniu Medical Instrument Co., Ltd (“Hangzhou Qingniu”)</td> <td style="white-space: nowrap"> </td> <td>Owned by immediate family member of Baiming Yu</td></tr> <tr style="vertical-align: top; "> <td>f</td> <td style="white-space: nowrap"> </td> <td>Qijia Yu</td> <td style="white-space: nowrap"> </td> <td>Immediate family member of Baiming Yu</td></tr> <tr style="vertical-align: top; background-color: rgb(204,238,255)"> <td>g</td> <td style="white-space: nowrap"> </td> <td>EZGO Technologies Ltd (“EZGO”)</td> <td style="white-space: nowrap"> </td> <td>A company significantly influenced by Shaung Wu in its management or operating policies</td></tr> </table>

COO, Director and a significant shareholder of the Group

Shuang Wu acted as the executive director and owned 30% equity interests of this related party

CEO, Director, and Chairman of the Board of Directors

55% equity interests owned by Baiming Yu

Owned by immediate family member of Baiming Yu

Immediate family member of Baiming Yu

A company significantly influenced by Shaung Wu in its management or operating policies

Amounts due from related parties consisted of the following for the periods indicated: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; "> <td> </td> <td style="font-weight: bold"> </td> <td style="font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold; text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Hangzhou Qingniu(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">4</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Hangzhou Shuige(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">19</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Huiyu Chuanggu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,474,926</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td>Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">15,276</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">9,310,000</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td>Qijia Yu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,943</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,404</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">EZGO(3)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">3,022,500</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">3,039,738</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">10,786,334</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The balance represents account receivables from related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">The balance represents advances made to the related parties for the Group’s daily operational purposes.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This balance represents a loan of $3,000,000 with an interest rate of 3% and will be matured on December 2026.</td> </tr></table>Amounts due to related parties consisted of the following for the periods indicated: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2" style="text-align: center"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%">Hangzhou Qingniu(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">7,028</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="padding-bottom: 1.5pt">Baiming Yu(1)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">-</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td> <td style="padding-bottom: 1.5pt"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: left"> </td> <td style="border-bottom: Black 1.5pt solid; text-align: right">12,772</td> <td style="padding-bottom: 1.5pt; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="font-weight: bold; padding-bottom: 4pt">Total</td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">7,028</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td> <td style="font-weight: bold; padding-bottom: 4pt"> </td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: left">$</td> <td style="border-bottom: Black 4pt double; font-weight: bold; text-align: right">12,772</td> <td style="padding-bottom: 2.5pt; font-weight: bold; text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">The balance represents an advance from this related party for the Group’s daily operations, which is interest-free and has no fixed repayment term.</td> </tr></table>

1474926

15276

9310000

1943

1404

3022500

3039738

10786334

7028

12772

7028

12772

<table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td style="font-weight: bold; border-bottom: Black 1.5pt solid">Nature</td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2026 (Unaudited)</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">2025 (Unaudited)</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Loan to Hangzhou Shuige(1)</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">-</td> <td style="width: 1%; text-align: left"> </td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left">$</td> <td style="width: 9%; text-align: right">107,872</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment from Hangzhou Shuige(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">436,336</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales to Hangzhou Shuige(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">185</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan from Hangzhou Shuige(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">428,198</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment to Hangzhou Shuige(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">428,198</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment to Baiming Yu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12,978</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan to Baiming Yu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">161,853</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Sales to Baiming Yu(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,184</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Sales to Hangzhou Qingniu(5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">10,203</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">34,708</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan to Hangzhou Qingniu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,383</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">74,681</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment from Hangzhou Qingniu(1&5)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">98,490</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Purchase from Hangzhou Qingniu(6)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,254</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan to Shuang Wu(1)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">92,885</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">628,294</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment from Shuang Wu(1&7)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,287,844</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,011,267</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Loan from Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">85,531</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">380,863</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Repayment to Shuang Wu(2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">85,531</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">364,329</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Advance to Huiyu Chuanggu(7)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">782,654</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Payment of equity transfer consideration on behalf of the Company(3)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">8,100,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Repayment to Huiyu Chuanggu for IPO costs paid on behalf of the Group (2)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">1,033,517</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Advance to Qijia Yu(4)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">2,074</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Reimbursement from Qijia Yu(4)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">492</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Loan to EZGO(8)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">3,000,000</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Interest receivable from EZGO(8)</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">22,500</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">-</td> <td style="text-align: left"> </td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(1)</td><td style="text-align: justify">These consisted of the Group’s interest-free loans, which are due on demand, to the related parties for their daily operations and repayment from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(2)</td><td style="text-align: justify">These consisted of the Group’s interest-free loans, which are due on demand, from the related parties for the Group’s daily operations or a portion of the IPO costs, including legal fees and accounting fees, and repayment to the related parties.</td> </tr></table><table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(3)</td><td style="text-align: justify">This consisted of the equity transfer consideration paid by Shuang Wu on behalf of the Company.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(4)</td><td style="text-align: justify">This consisted of the advances, which are interest-free and due on demand, made to the related parties for the Group’s daily operational purposes, and repayment and reimbursement from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(5)</td><td style="text-align: justify">These consisted of the receivables for selling medical consumables to the related parties and repayment from the related parties.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(6)</td><td style="text-align: justify">This consisted of the payable for purchase of materials from the related party.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(7)</td><td style="text-align: justify">These include: (i) repayments of borrowings from related parties for the Group’s daily operations; and (ii) prepayments for management services of financial administration, financial statement analysis, and financial planning advice.</td> </tr></table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">(8)</td><td style="text-align: justify">These consisted of an interest-bearing loan to the related party and corresponding interests.</td> </tr></table>

107872

436336

185

428198

12978

161853

3184

10203

34708

2383

74681

98490

2254

92885

628294

1287844

2011267

85531

380863

85531

364329

782654

8100000

1033517

2074

492

3000000

22500

50000

1:2000

50000 50000

50000

100000000

0.0005

87500000

0.0005

12500000

2091942

91942

5404654

50000

100000000

0.0005

250000

400000000

0.0005

one

100000000

0.0005

7592500

10000000

0.5

5000000

30000000

10000000

40000000

10000000

40000000

22055096

0.0005

16944238

0.075

2900000

0.0499 0.0999

0.0005

16944238

250000

400000000

0.0005

100000000

0.0005

10000000 250000

400000000

0.0005

100000000

0.0005

10000000

160000000

0.05

40000000

0.05

0.035

17100971

62329644

200000000 10000000

160000000

0.05

40000000

0.05

100000000

1600000000

0.05

400000000

0.05

100000000

16000000

4000000

100000

500000

1250

0.10 0.50

8049731

3235308

The following table sets forth a summary of single customers who represented 10% or more of the Group’s total accounts receivable: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom"> <td>Percentage of the Group’s total accounts receivable</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Customer A</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">42</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">*</td> <td style="width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer B</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">25</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">*</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Customer C</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">13</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">38</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Customer D</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">*</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">16</td> <td style="text-align: left">%</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Represent percentage less than 10%</td> </tr></table> The following table sets forth a summary of single suppliers who represented 10% or more of the Group’s total purchases: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="6" style="text-align: center; border-bottom: Black 1.5pt solid">For the six months ended March 31,</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2026</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td> <td style="font-weight: bold; padding-bottom: 1.5pt"> </td> <td colspan="2" style="font-weight: bold; text-align: center; border-bottom: Black 1.5pt solid">2025</td> <td style="padding-bottom: 1.5pt; font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td></tr> <tr style="vertical-align: bottom"> <td>Percentage of the Group’s total purchase</td> <td> </td> <td colspan="2"> </td> <td> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left">Supplier A</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">14</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">16</td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Supplier B</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">12</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">*</td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left">Supplier C</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">11</td> <td style="text-align: left">%</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">11</td> <td style="text-align: left">%</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; width: 100%; border-spacing: 0px;"> <tr style="vertical-align: top"> <td style="width: 0px"> </td> <td style="width: 24px">*</td> <td style="text-align: justify">Represent percentage less than 10%</td></tr> </table> The following table sets forth a summary of single suppliers who represented 10% or more of the Group’s total advance to suppliers: <table cellpadding="0" style="border-collapse: collapse; width: 100%; font: 10pt Times New Roman, Times, Serif; border-spacing: 0px;"> <tr style="vertical-align: bottom"> <td> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of March 31, 2026</td> <td style="padding-bottom: 1.5pt"> </td> <td style="padding-bottom: 1.5pt"> </td> <td colspan="2" style="text-align: center; border-bottom: Black 1.5pt solid">As of September 30, 2025</td> <td style="padding-bottom: 1.5pt"> </td></tr> <tr style="vertical-align: bottom"> <td> </td> <td style="font-weight: bold"> </td> <td colspan="2" style="font-weight: bold; text-align: center">(Unaudited)</td> <td style="font-weight: bold"> </td> <td> </td> <td colspan="2"> </td> <td> </td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left">Percentage of the Group’s advance to</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right"> </td> <td style="text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="width: 76%; text-align: left; text-indent: -10pt; padding-left: 10pt">Supplier D</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">91</td> <td style="width: 1%; text-align: left">%</td> <td style="width: 1%"> </td> <td style="width: 1%; text-align: left"> </td> <td style="width: 9%; text-align: right">51</td> <td style="width: 1%; text-align: left">%</td></tr> <tr style="vertical-align: bottom; "> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Supplier E</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">*</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">26</td> <td style="text-align: left">%</td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-align: left; text-indent: -10pt; padding-left: 10pt">Supplier F</td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">*</td> <td style="text-align: left"> </td> <td> </td> <td style="text-align: left"> </td> <td style="text-align: right">19</td> <td style="text-align: left">%</td></tr> </table> <table cellpadding="0" style="font: 10pt Times New Roman, Times, Serif; margin-top: 0pt; margin-bottom: 0pt; width: 100%; border-spacing: 0px;"><tr style="vertical-align: top; text-align: justify"> <td style="width: 0in"></td><td style="width: 0.25in; text-align: left">*</td><td style="text-align: justify">Represent percentage less than 10%</td> </tr></table>

0.42

0.25

0.13

0.38

0.16

0.14

0.16

0.12

0.11

0.91

0.51

0.26

0.19

3350000

4000000

0.03

P1Y

1200000

100

200000

16000000000

0.00001

4000000000 0.00001

200000

160000000

0.001

40000000

0.001

1128095

400000000

0001929783 false 2026-03-31 Q2 --09-30 Giving retroactive effect to the 100 to 1 Shares Consolidation on October 21, 2025, 100 to 1 Shares Consolidation on December 29, 2025, and 100 to 1 Shares Consolidation on June 18, 2026. Giving retroactive effect to the 100 to 1 Shares Consolidation on October 21, 2025, 100 to 1 Shares Consolidation on December 29, 2025, and 100 to 1 Shares Consolidation on June 18, 2026. Giving retroactive effect to the 100 to 1 Shares Consolidation on October 21, 2025, 100 to 1 Shares Consolidation on December 29, 2025, and 100 to 1 Shares Consolidation on June 18, 2026. On July 27, 2022, Work Hangzhou acquired 51% of the shares of Shanghai Saitumofei for a cash consideration of RMB100,000. Since then, Shanghai Saitumofei has become a subsidiary of the Group. On May 24, 2024, Work Hangzhou and the other original shareholders of Shanghai Saitumofei (collectively, the “Original Shareholders”) entered into a Capital Injection Agreement with Tunxi District Huangshan City Leading Industry Incubation Fund Ltd. (“Huangshan Fund”). According to the agreement, Huangshan Fund agreed to invest RMB20 million in cash to obtain 13.33% newly issued shares of Shanghai Saitumofei. Following the capital investment by Huangshan Fund, the Group’s ownership interest in Shanghai Saitumofei was diluted to 44.2017%. However, on May 24, 2024, the Original Shareholders entered into a concerted action agreement (the “Concerted Action Agreement”), to ensure that the Group retains majority voting rights (collectively 86.67%) in Shanghai Saitumofei. Under the Concerted Action Agreement, if the Original Shareholders cannot reach a consensus, Work Hangzhou’s opinion shall prevail. The Concerted Action Agreement has no fixed term and is irrevocable unless all parties consent unanimously. As a result, the Group is still required to consolidate Shanghai Saitumofei in the reporting entity in the scope of ASC 810 Consolidation. Medical devices are mainly anesthesia and respiratory consumables. In September 2025, the Company entered into agreements with Hangzhou Weishi Trading Co., Ltd. (“Hangzhou Weishi”), to lend up to RMB7,000,000 (approximately $983,284) to Hangzhou Weishi, with annualized interest rate at 4.00%, and due in September 2026. The Company has collected all the balance in February 2026. The balance as of March 31, 2026 mainly represented an interest-free loan to NEOLOGICS BIOSCIENCE INC. The balance represented the unamortized portion of prepayments made to certain service providers of the Group for their daily operations, which was expected to amortize over a period of less than 12 months. The balance as of March 31, 2026 mainly represented refundable equity investment prepayment of $2.0 million. In February 2026, Work Hangzhou entered into a property purchase agreement with a third party, to purchase a building at a price of RMB 40.30 million ($5.84 million). The balance represented unpaid purchase price as of March 31, 2026, and approximately RMB 12.90 million ($1.88 million) has been paid subsequently. In February 2026, Work Hangzhou acquired 13.33% shares of Shanghai Saitumofei owned by Huangshan Fund at a consideration of RMB 22.2 million ($3.22 million). The balance represented unpaid purchase price as of March 31, 2026, which has been fully paid as of the date of this unaudited condensed consolidated financial statements. The balance represents account receivables from related parties. The balance represents advances made to the related parties for the Group’s daily operational purposes. This balance represents a loan of $3,000,000 with an interest rate of 3% and will be matured on December 2026. The balance represents an advance from this related party for the Group’s daily operations, which is interest-free and has no fixed repayment term. These consisted of the Group’s interest-free loans, which are due on demand, to the related parties for their daily operations and repayment from the related parties. These consisted of the Group’s interest-free loans, which are due on demand, from the related parties for the Group’s daily operations or a portion of the IPO costs, including legal fees and accounting fees, and repayment to the related parties. This consisted of the equity transfer consideration paid by Shuang Wu on behalf of the Company. This consisted of the advances, which are interest-free and due on demand, made to the related parties for the Group’s daily operational purposes, and repayment and reimbursement from the related parties. These consisted of the receivables for selling medical consumables to the related parties and repayment from the related parties. This consisted of the payable for purchase of materials from the related party. These include: (i) repayments of borrowings from related parties for the Group’s daily operations; and (ii) prepayments for management services of financial administration, financial statement analysis, and financial planning advice.